# An Observational Study on the Safety and Efficacy of Immunotherapy Combined With Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma

> **NCT07080437** · — · RECRUITING · sponsor: **Three Gorges Hospital of Chongqing University** · enrollment: 40 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma (ESCC)

## Interventions

- **DRUG:** Immunotherapy Therapy

## Key facts

- **NCT ID:** NCT07080437
- **Lead sponsor:** Three Gorges Hospital of Chongqing University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-01
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-11-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07080437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07080437, "An Observational Study on the Safety and Efficacy of Immunotherapy Combined With Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07080437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*